> top > docs > PMC:7205724 > spans > 1463-1669 > annotations

PMC:7205724 / 1463-1669 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
51 47-50 Gene denotes IL6 Gene:3569
52 104-107 Gene denotes IL6 Gene:3569
61 85-93 Species denotes patients Tax:9606
62 148-157 Species denotes SARS-CoV2 Tax:2697049
64 4-15 Chemical denotes Tocilizumab MESH:C502936

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T5 30-38 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T6 158-162 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T18 148-152 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T5 17-18 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T6 158-162 http://purl.obolibrary.org/obo/GO_0005623 denotes cell

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T3 158-162 http://purl.obolibrary.org/obo/CL_0000000 denotes cell

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T18 148-157 Species denotes SARS-CoV2 NCBItxid:2697049

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T19 4-115 Sentence denotes Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
64 4-15 Chemical denotes Tocilizumab MESH:C502936
51 47-50 Gene denotes IL6 Gene:3569
61 85-93 Species denotes patients Tax:9606
52 104-107 Gene denotes IL6 Gene:3569
62 148-157 Species denotes SARS-CoV2 Tax:2697049

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T177 47-50 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0
T221 104-107 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T222 4-15 NNP denotes Tocilizumab
T223 15-16 -COMMA- denotes ,
T224 17-18 DT denotes a
T225 19-29 JJ denotes monoclonal
T226 30-38 NN denotes antibody
T227 39-46 IN denotes against
T228 47-50 NN denotes IL6
T229 50-51 -COMMA- denotes ,
T230 52-57 MD denotes could
T231 58-64 VB denotes confer
T232 65-73 JJ denotes clinical
T233 74-81 NN denotes benefit
T234 82-84 IN denotes in
T235 85-93 NNS denotes patients
T236 94-98 IN denotes with
T237 99-103 JJ denotes high
T238 104-107 NN denotes IL6
T239 108-114 NNS denotes levels
T240 116-125 JJ denotes Essential
T241 126-134 NNS denotes elements
T242 135-139 IN denotes that
T243 140-147 NN denotes process
T244 148-157 NN denotes SARS-CoV2
T245 158-162 NN denotes cell
T246 163-168 NN denotes entry
T247 169-172 CC denotes and
T248 173-181 JJ denotes specific
T249 182-197 NNS denotes characteristics
T250 198-202 WDT denotes that
R213 T222 T223 arg1Of Tocilizumab,","
R214 T226 T223 arg2Of antibody,","
R215 T226 T224 arg1Of antibody,a
R216 T226 T225 arg1Of antibody,monoclonal
R217 T226 T227 arg1Of antibody,against
R218 T228 T227 arg2Of IL6,against
R219 T231 T229 arg1Of confer,","
R220 T222 T230 arg1Of Tocilizumab,could
R221 T231 T230 arg2Of confer,could
R222 T222 T231 arg1Of Tocilizumab,confer
R223 T233 T231 arg2Of benefit,confer
R224 T233 T232 arg1Of benefit,clinical
R225 T231 T234 arg1Of confer,in
R226 T235 T234 arg2Of patients,in
R227 T235 T236 arg1Of patients,with
R228 T239 T236 arg2Of levels,with
R229 T239 T237 arg1Of levels,high
R230 T239 T238 arg1Of levels,IL6
R231 T241 T240 arg1Of elements,Essential
R232 T241 T242 arg1Of elements,that
R233 T247 T242 arg2Of and,that
R235 T246 T243 arg1Of entry,process
R236 T246 T244 arg1Of entry,SARS-CoV2
R237 T246 T245 arg1Of entry,cell
R238 T246 T247 arg1Of entry,and
R239 T249 T247 arg2Of characteristics,and
R240 T249 T248 arg1Of characteristics,specific
R241 T249 T250 arg1Of characteristics,that

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T5 30-38 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T6 158-162 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T18 148-157 Disease denotes SARS-CoV2 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T19 4-115 Sentence denotes Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels.